SCHEMBL28125976

SCHEMBL28125976

Cc1cc(Br)ccc1CN1CC(OC(C)(C)C)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 3/20 0.36
▸ S1PR5 Q9H228 3/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ PYCR1 P32322 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ PRKD3 O94806 1/20 0.33
▸ CDK7 P50613 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ TNK2 Q07912 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ TRPV6 Q9H1D0 1/20 0.32
▸ NPY1R P25929 1/20 0.32
▸ NPY2R P49146 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28126278 0.83 NR1H2 (0.40) KDM4ETDP1MEN1KMT2A
SCHEMBL16793935 0.78 BTK (0.47) ALDH1A1CDK7
SCHEMBL15094020 0.72 KDM4E (0.42) KDM4ETDP1ALDH1A1TSHRKMT2A
SCHEMBL3878573 0.72 TSHR (0.58) KDM4ETDP1ALDH1A1TSHRMEN1
SCHEMBL15093922 0.70 MGLL (0.51) KDM4EALDH1A1MEN1KMT2A
SCHEMBL2800989 0.70 KMT2A (0.60) KDM4ETDP1ALDH1A1TSHRKMT2A
SCHEMBL21551100 0.70 KDM4E (0.49) KDM4ETDP1ALDH1A1TSHRKMT2A
SCHEMBL2802106 0.69 CYP2A13 (0.61) KDM4ETDP1ALDH1A1KMT2A
SCHEMBL3641216 0.69 KDM4E (0.56) KDM4EALDH1A1
SCHEMBL20198190 0.69 LMNA (0.59) KDM4ETDP1ALDH1A1TSHRGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459002-A Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases 比奥根MA公司 2017-02-22 — — CN disclosed
Send feedback